Asia Pacific home healthcare device and equipment market will grow by 9.0% annually with a total addressable market cap of $133.0 billion over 2021-2030 owing to the aging population worldwide, the prevalence of infectious diseases as well as the increasing prevalence of chronic diseases, technological innovation, and penetration of healthcare insurance.
Highlighted with 42 tables and 57 figures, this 135-page report 鈥淎sia Pacific 麻豆原创 Healthcare Device and Equipment 麻豆原创 2020-2030 by Product Type (Therapeutic, Patient Monitoring, Mobility Assist), Disease, Distribution Channel, and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire Asia Pacific home healthcare device and equipment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
鈥� 麻豆原创 Structure
鈥� Growth Drivers
鈥� Restraints and Challenges
鈥� Emerging Product Trends & 麻豆原创 Opportunities
鈥� Porter鈥檚 Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific home healthcare device and equipment market in every aspect of the classification from perspectives of Product Type, Disease, Distribution Channel, and Country.
Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
鈥� Therapeutic Equipment
o 麻豆原创 Respiratory Therapy Equipment
飪� Oxygen Delivery Equipment (ODE) (ODE is further split into 麻豆原创 Liquid Oxygen Containers, Oxygen Cannula, Oxygen Concentrators, Other 麻豆原创 Oxygen Delivery Equipment)
飪� Continuous Positive Airways Pressure Equipment (CPAP) (further segmented into CPAP Masks & Related Interfaces, CPAP Machines, CPAP Accessories)
飪� Humidifiers
飪� Nebulizers
飪� Ventilators
o 麻豆原创 IV Equipment
飪� IV Pumps
飪� IV Administration Sets
飪� Premixed IV Devices
飪� IV Catheters
飪� Injection Devices
飪� IV Accessories
o 麻豆原创 Dialysis Equipment
飪� 麻豆原创 Hemolysis Products
飪� 麻豆原创 Peritoneal Dialysis
o Other 麻豆原创 Therapeutic Equipment
飪� 麻豆原创 Physical Therapy Equipment
飪� 麻豆原创 Automated External Defibrillators
飪� 麻豆原创 Enteral Feeding Products
飪� 麻豆原创 Negative Pressure Wound Therapy Devices
飪� 麻豆原创 Braces & Related Products
飪� 麻豆原创 Muscle & Nerve Stimulators
鈥� Patient Monitoring Equipment
o Blood Pressure Monitors
o Blood Glucose Monitors
o Coagulation Monitors
o Baby Monitors
o Heart Rate Monitor
o Apnea Monitors
o Electronic Thermometer
o Peak Flow Monitors
o Holter Monitors
o Remote Patient Monitoring Systems
o Real-Time Telemedicine Systems
o Other Patient Monitoring Equipment
鈥� Mobility Assist & Patient Support Equipment
o Mobility Assist Equipment
飪� Wheelchairs
飪� Scooters
飪� Canes & Crutches
飪� Walkers & Rollators
飪� Stair Lifts
o 麻豆原创 Healthcare Furniture
飪� Lift Chairs
飪� Medical Beds
飪� Other 麻豆原创 Healthcare Furniture
o Bathroom Safety Equipment
飪� Commodes
飪� Shower Chairs
飪� Elevated Toilet Seats
飪� Bars, Grips, & Rails
Based on Disease, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
鈥� Diabetes
鈥� Motion Impairments
鈥� Respiratory Diseases
鈥� Sleep Disorder
鈥� Kidney Failure
鈥� Hypertension
鈥� Other Diseases
Based on Distribution Channel, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
鈥� Retail Pharmacy
鈥� Hospitals
鈥� Online Stores
Geographically, the following national/local markets are fully investigated:
鈥� Japan
鈥� China
鈥� South Korea
鈥� Australia
鈥� India
鈥� Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of key national markets by Product Type, Disease, and Distribution Channel over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories Inc.
Baxter International Inc.
Becton, Dickinson and Co.
Braun Melsungen AG
CAIRE Inc.
ConvaTec Group plc
Drive DeVilbiss Healthcare
Fresenius Medical Care Holdings, Inc.
General Electric Company
Hill-Rom Holdings, Inc.
Inogen, Inc.
Invacare Corporation
Johnson & Johnson
Koninklijke Philips N.V.
Medtronic Plc
O2 Concepts, LLC
ResMed Inc.
Smith & Nephew Plc
Stryker Corp.
Sunrise Medical (US) LLC
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of 麻豆原创 Research Methodology 12
1.2.2 麻豆原创 Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 15
1.2.6 麻豆原创 Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 麻豆原创 Overview and Dynamics 20
2.1 麻豆原创 Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the 麻豆原创 23
2.2 Major Growth Drivers 25
2.3 麻豆原创 Restraints and Challenges 28
2.4 Emerging Opportunities and 麻豆原创 Trends 31
2.5 Porter鈥檚 Fiver Forces Analysis 35
3 Segmentation of Asia Pacific 麻豆原创 by Product Type 41
3.1 麻豆原创 Overview by Product Type 41
3.2 Therapeutic Equipment 43
3.2.1 麻豆原创 Respiratory Therapy Equipment 45
3.2.2 麻豆原创 IV Equipment 47
3.2.3 麻豆原创 Dialysis Equipment 49
3.2.4 Other 麻豆原创 Therapeutic Equipment 50
3.3 Patient Monitoring Equipment 52
3.3.1 Blood Pressure Monitors 54
3.3.2 Blood Glucose Monitors 55
3.3.3 Coagulation Monitors 56
3.3.4 Baby Monitors 57
3.3.5 Heart Rate Monitor 58
3.3.6 Apnea Monitors 59
3.3.7 Electronic Thermometer 60
3.3.8 Peak Flow Monitors 61
3.3.9 Holter Monitors 62
3.3.10 Remote Patient Monitoring Systems 63
3.3.11 Real-Time Telemedicine Systems 64
3.3.12 Other Patient Monitoring Equipment 65
3.4 Mobility Assist & Patient Support Equipment 66
3.4.1 Mobility Assist Equipment 68
3.4.2 麻豆原创 Healthcare Furniture 69
3.4.3 Bathroom Safety Equipment 70
4 Segmentation of Asia Pacific 麻豆原创 by Disease 71
4.1 麻豆原创 Overview by Disease 71
4.2 Diabetes 73
4.3 Motion Impairments 74
4.4 Respiratory Diseases 75
4.5 Sleep Disorder 76
4.6 Kidney Failure 77
4.7 Hypertension 78
4.8 Other Diseases 79
5 Segmentation of Asia Pacific 麻豆原创 by Distribution Channel 80
5.1 麻豆原创 Overview by Distribution Channel 80
5.2 Retail Pharmacy 82
5.3 Hospitals 83
5.4 Online Stores 84
6 Asia-Pacific 麻豆原创 2019-2030 by Country 85
6.1 Overview of Asia-Pacific 麻豆原创 85
6.2 Japan 88
6.3 China 91
6.4 Australia 94
6.5 India 97
6.6 South Korea 99
6.7 Rest of APAC Region 101
7 Competitive Landscape 103
7.1 Overview of Key Vendors 103
7.2 New Product Launch, Partnership, Investment, and M&A 107
7.3 Company Profiles 108
Abbott Laboratories Inc. 108
Baxter International Inc. 110
Becton, Dickinson and Co. 111
Braun Melsungen AG 112
CAIRE Inc. 113
ConvaTec Group plc 114
Drive DeVilbiss Healthcare 115
Fresenius Medical Care Holdings, Inc. 116
General Electric Company 117
Hill-Rom Holdings, Inc. 118
Inogen, Inc. 119
Invacare Corporation 120
Johnson & Johnson 121
Koninklijke Philips N.V. 122
Medtronic Plc 123
O2 Concepts, LLC 124
ResMed Inc. 125
Smith & Nephew Plc 126
Stryker Corp. 127
Sunrise Medical (US) LLC 128
8 Investing in Asia Pacific 麻豆原创: Risk Assessment and Management 129
8.1 Risk Evaluation of Asia Pacific 麻豆原创 129
8.2 Critical Success Factors (CSFs) 132
Related Reports and Products 135
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories Inc.
Baxter International Inc.
Becton, Dickinson and Co.
Braun Melsungen AG
CAIRE Inc.
ConvaTec Group plc
Drive DeVilbiss Healthcare
Fresenius Medical Care Holdings, Inc.
General Electric Company
Hill-Rom Holdings, Inc.
Inogen, Inc.
Invacare Corporation
Johnson & Johnson
Koninklijke Philips N.V.
Medtronic Plc
O2 Concepts, LLC
ResMed Inc.
Smith & Nephew Plc
Stryker Corp.
Sunrise Medical (US) LLC
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
听
听
*If Applicable.